Zynex served as a Colorado startup success story — a one-man operation turned public company with hundreds of millions of dollars in revenue. This is the story about how it all fell apart.
A federal securities class action filed on February 20, 2026 has laid bare what prosecutors describe as an $873 million insurance billing fraud machine run by the former top executives of medical ...
LOS ANGELES, April 09, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming May 19, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf ...
NEW YORK, April 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class period ...
Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Zynex, Inc. (NASDAQ: ZYKIQ) securities between February 25, 2021 and ...
SAN FRANCISCO, April 09, 2025 (GLOBE NEWSWIRE) -- Shares of Zynex Inc. (NASDAQ: ZYXI), a medical device manufacturer specializing in nerve stimulation products, are trading down 65% over the past ...
ENGLEWOOD, Colo., Jan. 22, 2026 /PRNewswire/ -- Zynex, Inc. (ZYXIQ), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
NEW YORK, NY / ACCESS Newswire / May 4, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a potential recovery under the federal securities laws, ...
Zynex Inc ( (ZYXI)) has released its Q3 earnings. Here is a breakdown of the information Zynex Inc presented to its investors. Zynex, Inc. is a medical technology company that develops, manufactures, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results